We are live on ! Find out more
MED icon

Medifast

129 hedge funds and large institutions have $157M invested in Medifast in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 46 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more call options, than puts

Call options by funds: $7.05M | Put options by funds: $5.68M

2.2% less ownership

Funds ownership: 83.76% → 81.56% (-2.2%)

8% less funds holding

Funds holding: 140 → 129 (-11)

20% less capital inflows, than outflows

Capital inflows: $18.5M | Capital outflows: $23.2M

26% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 46

58% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 31

Holders
129
Holders Change
-11
Holders Change %
-7.86%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
34
Reduced
46
Closed
31
Calls
$7.05​M
Puts
$5.68​M
Net Calls
+$1.37​M
Net Calls Change
-⁠$4.67​M

MED Hedge Fund Activity: Q4 2024 in Review

129 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2024, worth a combined $157M — down 10% from $175M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of MED and 13 opened new positions — a net loss of 18 holders — while 46 trimmed existing stakes and 34 added.

The largest buyer was Prescott Group Capital Management, opening a new position worth an estimated $2.04M. The largest seller was AQR Capital Management, cutting an estimated $3.9M.

  • 129 institutional investors held Medifast (MED) as of Q4 2024, down from 140 in Q3 2024.
  • Funds reported $157M of Medifast stock for Q4 2024, down 10% quarter-over-quarter.
  • 13 funds opened new Medifast positions in Q4 2024 and 31 closed out, a net change of -18 holders.
  • The largest Medifast buyer in Q4 2024 was Prescott Group Capital Management, an estimated $2.04M added.
  • The largest Medifast seller in Q4 2024 was AQR Capital Management, an estimated $3.9M sold.

Based on aggregated 13F filings for Q4 2024.